Asthma is the most common chronic disease of childhood. Children with asthma frequently present in the acute care setting with disease ranging from mild to severe. Accurately assessing children with asthma and providing escalating care as needed improves outcome. The authors provide a current review of asthma and evidence-based care.
The disease associated with the 2019 novel coronavirus (COVID-19) is now a significant event in world history, with uncertain but likely major consequences for individuals, families, healthcare workers, health systems, and the global economy. Although COVID-19 appears to pose only a limited danger to children, older adults face the possibility of much more serious manifestations. At this time it seems COVID-19 will demand the attention of most practitioners and allied health providers over the next year. Thus, familiarization with what is known so far about its pathophysiology, epidemiologic risk factors, treatment, and future directions for research is important as we face and fight this crisis united as healthcare providers.
The NYU Grossman School of Medicine’s working group on Pediatric Gene Therapy and Medical Ethics formed in the fall of 2019 to address and propose recommendations to issues involving gene-based therapies in pediatric populations, including research activities.
Emergency medicine providers commonly will encounter children with type 1 and type 2 diabetes. Unfortunately, the incidence of both is increasing, and the acute care provider must be able to recognize the subtle and dramatic presentations of both diseases. Early recognition and management of both the disease and its complications — diabetic ketoacidosis, hyperglycemic hyperosmolar state, and cerebral edema — are critical to ensure an optimal outcome.
Multiple professional organizations have released a policy statement that heralds the initial step in an ambitious effort aimed at promoting pediatric readiness in the prehospital environment. The move follows in the footsteps of the successful National Pediatric Readiness Project, which continues to push for improvements in the preparedness level of EDs across the country to care for children.
Rash is a common complaint in the emergency department (ED). Often, the pediatric rash is a benign, self-limiting condition that requires no intervention; however, there are occasions when rashes are true emergencies. Identifying these rare occasions is critical for the pediatric patient. This issue reviews and discusses some of the most common pediatric dermatologic emergencies and the ED approach to identification, diagnosis, and immediate evidence-based management of these conditions.
Research findings may suggest clinicians do not recognize ethical dilemmas other than treatment-related decision-making and care goals at life’s end. More education could help medical teams identify important ethical issues and to call on the proper resources to address those issues when needed.